Question 1

Does Avoro Capital Advisors own SRPT stock?

Accepted Answer

No. Avoro Capital Advisors exited its SRPT (Sarepta Therapeutics) position in Q2 2025. Its Q1 2025 13F listed 2,674,835 shares worth $170.7M.

Question 2

How many shares of SRPT does Avoro Capital Advisors own?

Accepted Answer

None since Q2 2025, when Avoro Capital Advisors exited the position. Its Q1 2025 13F listed 2,674,835 shares worth $170.7M.

Question 3

What is Avoro Capital Advisors' SRPT position worth?

Accepted Answer

Avoro Capital Advisors' SRPT position was worth $170.7M in its Q1 2025 13F, before the exit in Q2 2025.

Question 4

Is Avoro Capital Advisors buying or selling SRPT?

Accepted Answer

In Q2 2025, Avoro Capital Advisors exited its entire SRPT position.

Question 5

When did Avoro Capital Advisors first buy SRPT?

Accepted Answer

Avoro Capital Advisors already held SRPT in its Q1 2019 13F, the earliest on record, and listed it in 25 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q2 Latest	Exited	0	-100.0%	$0	0.0%	$17.10	0
2025-Q1	Increased	2.7M	+4.7%	$170.7M	2.7%	$63.82	56
2024-Q4	Unchanged	2.6M	0.0%	$310.7M	4.4%	$121.59	0
2024-Q3	Decreased	2.6M	-14.8%	$319.2M	4.7%	$124.89	0